Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 6, 2021; 9(31): 9440-9451
Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9440
Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9440
Derivation cohort (n = 796) | Validation cohort (n = 448) | ||||||
Favorable outcome | Unfavorable outcome | P | Favorable outcome | Unfavorable outcome | P | ||
n = 750 | n = 46 | n = 423 | n = 25 | ||||
Age, median (IQR) | 63 (52, 71) | 64.5 (59, 72) | 0.26 | 63 (52, 70) | 69 (62, 75) | 0.03 | |
Sex | 0.87 | 0.01 | |||||
Female | 217 (28.9%) | 14 (30.4%) | 132 (31.2%) | 2 (8.0%) | |||
Male | 533 (71.1%) | 32 (69.6%) | 291 (68.8%) | 23 (92.0%) | |||
Hypertension | 469 (62.5%) | 26 (56.5%) | 0.44 | 261 (61.7%) | 17 (68.0%) | 0.67 | |
Diabetes | 229 (30.5%) | 18 (39.1%) | 0.25 | 99 (23.4%) | 3 (12.0%) | 0.23 | |
FPG, median (IQR) | 5.6 (5, 7.33) | 5.915 (4.66, 7.22) | 0.67 | 5.41 (4.89, 6.65) | 4.85 (4.57, 5.45) | 0.02 | |
Cardiopathy | 59 (7.9%) | 7 (15.2%) | 0.09 | 40 (9.5%) | 7 (28.0%) | < 0.01 | |
Smoking | 188 (25.1%) | 15 (32.6%) | 0.29 | 100 (23.6%) | 11 (44.0%) | 0.03 | |
UA, median (IQR) | 298 (243, 359) | 280 (179, 332) | 0.04 | 306 (238, 364) | 298 (179, 354) | 0.61 | |
UN, median (IQR) | 5.3 (4.48, 6.54) | 4.82 (3.81, 6.36) | 0.11 | 5.5 (4.38, 6.98) | 5.8 (3.81, 6.3) | 0.34 | |
Hcy, median (IQR) | 13.96 (11.07, 19.03) | 13.56 (10.01, 18.4) | 0.33 | 14.04 (10.53, 17.6) | 16.43 (10.01, 26.82) | 0.18 | |
CRP, median (IQR) | 1.415 (0.51, 6.13) | 1.325 (0.6, 3.9) | 0.58 | 1.62 (0.56, 4.7) | 1.56 (0.89, 3.57) | 0.94 | |
TC, median (IQR) | 4.435 (3.84, 5.2) | 4.89 (3.96, 5.36) | 0.08 | 4.4 (3.89, 5.04) | 5.02 (3.49, 5.75) | 0.16 | |
TG, median (IQR) | 1.52 (1.08, 2.12) | 1.72 (1.32, 2.45) | 0.09 | 1.47 (1.06, 2.05) | 1.38 (0.89, 1.86) | 0.46 | |
LDLC, median (IQR) | 2.615 (2.04, 3.25) | 3.15 (2.34, 3.52) | 0.03 | 2.57 (2.14, 3.19) | 3.26 (2.3, 3.71) | 0.04 | |
Stable plaques | 288 (38.4%) | 18 (39.1%) | 1.00 | 147 (34.8%) | 6 (24.0%) | 0.39 | |
Vulnerable plaque | 400 (53.3%) | 21 (45.7%) | 0.36 | 217 (51.3%) | 10 (40.0%) | 0.31 | |
Alcohol drinking | 256 (34.1%) | 18 (39.1%) | 0.52 | 131 (31.0%) | 11 (44.0%) | 0.19 | |
HDLC, median (IQR) | 1.1 (0.94, 1.36) | 1.145 (0.9, 1.28) | 0.56 | 1.12 (0.95, 1.37) | 1.14 (1.05, 1.46) | 0.47 | |
APOA, median (IQR) | 1.35 (1.21, 1.55) | 1.415 (1.19, 1.58) | 0.56 | 1.35 (1.22, 1.54) | 1.46 (1.19, 1.53) | 0.47 | |
APOB, median (IQR) | 0.925 (0.73, 1.09) | 1.1 (0.84, 1.22) | < 0.01 | 0.91 (0.73, 1.08) | 1 (0.75, 1.16) | 0.46 | |
LP(a), median (IQR) | 208.5 (112, 340) | 173.5 (124, 371) | 0.78 | 187 (106, 329) | 151 (129, 371) | 0.99 | |
Cr, median (IQR) | 55.65 (14.72, 72.1) | 65.1 (48.6, 80) | < 0.01 | 55.9 (14.7, 69.8) | 70.2 (48.8, 78.3) | 0.01 | |
STBL, median (IQR) | 17.985 (11.7, 58) | 15.11 (11.5, 19.03) | 0.02 | 17.23 (11.7, 60.2) | 14.86 (11.5, 17.3) | 0.19 | |
Ferritin, median (IQR) | 220.85 (136.59, 324.3) | 255.57 (218.1, 426.1) | < 0.01 | 207.18 (131.2, 318.78) | 252.2 (191.83, 350.6) | 0.09 | |
GHb, median (IQR) | 6.66 (5.82, 7.94) | 7.18 (6.3, 9.09) | 0.14 | 5.82 (4.68, 7.4) | 5.91 (4.53, 6.72) | 0.33 | |
SBP, median (IQR) | 142 (130, 158) | 147 (139, 163) | 0.08 | 140 (129, 155) | 140 (120, 154) | 0.49 | |
DBP, median (IQR) | 82 (75, 92) | 84.5 (80, 90) | 0.48 | 82 (75, 91) | 89 (81, 90) | 0.28 |
- Citation: Yu XF, Yin WW, Huang CJ, Yuan X, Xia Y, Zhang W, Zhou X, Sun ZW. Risk factors for relapse and nomogram for relapse probability prediction in patients with minor ischemic stroke. World J Clin Cases 2021; 9(31): 9440-9451
- URL: https://www.wjgnet.com/2307-8960/full/v9/i31/9440.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i31.9440